Search - tctmd.com

Displaying 1 - 20 of 54

Sort: Relevancy | Date

News Daily News

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

Todd Neale

July 31, 2025

News Daily News

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

Caitlin E. Cox

February 14, 2025

News Daily News

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Michael O'Riordan

March 15, 2024

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Conference News AHA 2021

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Caitlin E. Cox

November 13, 2021

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News CV Team Pro

NorthShore University Health System

L.A. McKeown

December 30, 2020

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Conference News CRT 2020

Long-term Survival Data Promising for Carillon Repair Device in Functional MR

L.A. McKeown

March 03, 2020

News Daily News

Routine Anticoagulation Seems Warranted After TMVR: Review

Todd Neale

December 04, 2019

News Daily News

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

Shelley Wood

August 20, 2019

News Conference News TVT 2019

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Michael O'Riordan

June 14, 2019

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Conference News TCT 2018

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Yael L. Maxwell

September 23, 2018

News Conference News The Structural Heart Disease Summit 2018

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Shelley Wood

June 22, 2018

News Daily News

Edwards Voluntarily Recalls Cardioband ‘Anchors’ Used in Mitral and Tricuspid Repair

Michael O'Riordan

February 27, 2018

News Industry News

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 24, 2018

News Conference News TCT 2017

Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key

Yael L. Maxwell

November 10, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Advertisement

Infective Endocarditis Risk Much Higher a Decade After MV Replacement vs Repair

ELASTA-Clip Plus TMVR Safe, Feasible for Failed M-TEER

M-TEER Outcomes at 1 Year Best at Hospitals With High Mitral Surgical Volumes

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Modified Surgical MV Repair Stands Up to Replacement

Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years

Failed MitraClip Is Uncommon, but Bleak When It Happens

NorthShore University Health System

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Long-term Survival Data Promising for Carillon Repair Device in Functional MR

Routine Anticoagulation Seems Warranted After TMVR: Review

Late Follow-up of Surgical MV Repair: Insights for Timing, Innovation

What’s The Future For Treating Mitral Valve Disease: Repair, Replace, or Combination Approaches?

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Edwards Voluntarily Recalls Cardioband ‘Anchors’ Used in Mitral and Tricuspid Repair

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

Valve-in-Ring, Valve-in-MAC TMVR Procedures Feasible, but Patient Selection Is Key

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content